NCT07168785View on ClinicalTrials.gov

[18F]-AraG PET Imaging in LA HNSCC

EARLY_PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

October 31, 2027

Conditions
Head and Neck Squamous Cell Carcinoma (HNSCC)Locally Advanced Head and Neck Squamous Cell Carcinoma
Interventions
DRUG

[18F]-AraG radiotracer

\[18F\]-AraG radiotracer, which occurs on the first and sixteenth day of treatment.

DRUG

Chemotherapy

Concurrent chemoradiotherapy (CRT) with weekly doses of cisplatin.

DEVICE

Radiotherapy

Concurrent chemoradiotherapy (CRT) of 70Gy of radiation dose in 33 fractions.

Trial Locations (1)

46202

Indiana University, Indianapolis

Sponsors
All Listed Sponsors
collaborator

CellSight Technologies, Inc.

INDUSTRY

lead

Indiana University

OTHER